Disclosing marketing payments to physicians resulted in a robust decline in both branded and generic prescriptions in three best-seller classes, likely because of physician self-monitoring.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: